Zepbound
Active Ingredient(s): TirzepatideFDA Approved: * November 8, 2023
Pharm Company: * ELI LILLY AND CO
Category: Diabetes
* May have multiple approval dates, manufacturers, or labelers.
Dosage List
Zepbound 12.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2460
Labeler:
Eli Lilly and Company